PBK and skin squamous cell carcinoma: Knocking down the expression of TOPK in cSCC cells by small molecule interference technology significantly reduced the invasion and metastasis ability of cancer cells, while upregulating TOPK expression could further promote malignant progress; this is consistent with other scholars' reports [7–9], suggesting that TOPK can acts as potential target in treatment of cSCC.